Skip to content
glp1.howSign in

Supportive Health

Men's health on a GLP-1: testosterone, fertility, muscle, and the things worth watching

For men, losing weight on a GLP-1 can raise testosterone that obesity was holding down, and unlike testosterone therapy it seems to leave fertility intact. This guide covers what the research shows so far on testosterone, sexual function and sperm, muscle and bone, heart health and sleep apnea, and why the routine checkup matters more on these medications.

By the glp1.how editorial teamReviewed 4 min read

Evidence-backed

In a 2025 meta-analysis of men on GLP-1 medications, total testosterone rose significantly, and the more weight men lost, the more it rose (Salvio et al., Andrology, 2025, DOI (external link)). For many men with excess weight, part of what a GLP-1 does is undo a hormone problem the weight was causing. Below is what the research shows for men, and where it is solid versus still early.

Weight loss can raise testosterone, often without testosterone therapy

Excess weight lowers measured testosterone. Much of the drop comes from lower levels of SHBG, the protein that carries testosterone in the blood, and fat tissue also converts some testosterone to estrogen. In most men with obesity, the brain signals to the testes (LH and FSH) are normal, and the low reading is a reversible consequence of the weight rather than a failing gland. Clinically significant weight loss largely reverses it (Muir, Wittert & Handelsman, Journal of Clinical Endocrinology & Metabolism, 2025, DOI (external link)).

The GLP-1 data fit that picture. Across systematic reviews, GLP-1 use in men with obesity or type 2 diabetes was consistently associated with higher total testosterone, and the rise tracked the amount of weight lost (Salvio et al., Andrology, 2025, DOI (external link); Deameh et al., Journal of Sexual Medicine, 2026, DOI (external link)). So if you've been told your testosterone is low and you also carry excess weight, losing weight may be worth trying before you commit to lifelong testosterone therapy. Talk it through with your prescriber; our guide on testosterone therapy and GLP-1 medications goes into it in detail.

The fertility difference between a GLP-1 and testosterone therapy

Many men don't know that testosterone therapy (TRT) can cause infertility. Supplemental testosterone tells the brain to cut back LH and FSH, the hormones that drive sperm production (Muir et al., 2025).

GLP-1 medications appear to work the other way. In the reviews, LH and FSH were preserved or increased on GLP-1s, in contrast to the suppression seen with testosterone therapy, which is why researchers describe them as a potential fertility-sparing route to higher testosterone in obesity-related low T (Deameh et al., Journal of Sexual Medicine, 2026, DOI (external link)). If you want to father children, that difference matters a lot.

Sexual function and sperm: promising, but still early

There are two related signals, both real and both based on limited data.

Weight loss improves erectile function in men with overweight, and a meta-analysis found GLP-1 use was associated with better erectile-function scores alongside greater weight loss (Salvio et al., Andrology, 2025, DOI (external link)).

Semen quality improved in men with obesity or hypogonadism, but not in men who were already healthy, and the studies are small (Deameh et al., Journal of Sexual Medicine, 2026, DOI (external link)).

If poor metabolic health was dragging these down, improvement is plausible and consistent across studies. But a GLP-1 is not a fertility or erectile-dysfunction treatment, the evidence is thin, and online "boost your testosterone" claims run well ahead of it. Treat any gains as a side effect of getting healthier, not a reason to start.

Protect your muscle and your bones

A meaningful share of the weight lost on a GLP-1 is lean mass, and reviews flag the risk of muscle loss and weaker bones, a bigger concern for men who already have low testosterone (Antonič & Zitzmann, The Aging Male, 2025, DOI (external link)). Losing weight but ending up weaker is a bad trade.

The countermeasures are the same as for everyone, and they matter more here: resistance training to signal your body to keep muscle (see why strength training matters on a GLP-1) and enough protein while your appetite is low (high-protein meals and snacks when your appetite is low). Lift and eat protein, and more of what you lose will be fat.

Heart health and the routine checkup

Men carry higher baseline cardiovascular risk. In a large 2025 real-world study, GLP-1 use in adults with obesity was associated with lower rates of major adverse cardiovascular events and all-cause mortality compared with other weight-loss medications (Tang et al., Diabetes, Obesity & Metabolism, 2025, DOI (external link)). The randomized-trial evidence behind that signal is in our guide to the cardiovascular benefits of GLP-1 medications. Getting the most from it means doing the routine part: baseline and follow-up labs (including testosterone if you have symptoms), blood pressure checks, and keeping your appointments.

Sleep apnea: more common in men, and now directly treatable

Obstructive sleep apnea is more common in men, strongly tied to excess weight, and easy to dismiss as "just snoring." It matters more on a GLP-1 for two reasons. Short sleep can tilt weight loss toward muscle (in one small controlled study, people on the same diet lost more lean mass when they slept less; see sleep quality on a GLP-1). And since December 2024, one GLP-1 medication, tirzepatide (Zepbound), has been FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity. If you snore heavily, wake unrefreshed, or your partner notices you stop breathing, raise it with your doctor; our guide to getting a sleep study covers the next steps. If you already use CPAP, see managing CPAP as the weight comes off.

This article is general education, not medical advice. Testosterone, fertility, and cardiovascular decisions are individual, so discuss your labs and symptoms with your prescriber. The male-reproductive research here is early and based on small studies. Research findings above are attributed to PubMed-indexed articles with DOI links.

mens-healthtestosteronefertilitymusclecardiovascularsleep-apneasupportive-health

Common questions

Questions people often ask about this topic.

  • Can a GLP-1 raise my testosterone?

    Often, yes, if you carry excess weight. Extra weight lowers measured testosterone, so a lot of "low T" in heavier men is a reversible, weight-driven state. Across systematic reviews, GLP-1 use was associated with higher total testosterone, and the rise tracked how much weight men lost. For some men that means losing weight can lift testosterone without starting lifelong testosterone therapy. Talk it through with your prescriber.

  • Is a GLP-1 better than testosterone therapy for fertility?

    They work very differently for fertility. Testosterone therapy suppresses the hormones (LH and FSH) that drive sperm production and can cause infertility. In the research, GLP-1s preserved or increased those hormones instead, which is why they're described as a potentially fertility-sparing way to raise testosterone in obesity-related low T. If fathering children matters to you, raise this specifically with your prescriber.

  • Will a GLP-1 help with erectile dysfunction or sperm quality?

    The early signals are promising but not proven. Weight loss improves erectile function, and studies link GLP-1 use to better erectile scores and to improved semen quality in men with obesity or low testosterone, though not in men who were already healthy, and the studies are small. Treat any improvement as a side effect of getting healthier, not as a fertility or ED treatment, and be skeptical of online hype that runs ahead of the evidence.

  • How do I avoid losing muscle on a GLP-1 as a man?

    A meaningful share of the weight lost on a GLP-1 is lean mass, and that muscle and bone loss is a bigger concern for men with low testosterone. The countermeasures are resistance training, which signals your body to keep muscle, and getting enough protein while your appetite is low. Lifting and eating enough protein shifts more of what you lose toward fat.

  • What should men make sure to check with their doctor on a GLP-1?

    The routine basics: baseline and follow-up labs (including testosterone if you have symptoms of low T), blood pressure, and keeping your appointments. GLP-1s are associated with lower cardiovascular and mortality risk in people with obesity, and regular follow-up is how you and your doctor track that. If you snore heavily or wake unrefreshed, ask about sleep apnea too. It's common in men, and since December 2024 tirzepatide has been approved to treat moderate-to-severe cases in adults with obesity.

Evidence

The sources behind this article, labeled by type and strength.

Supporting6

Mixed findings1

Revision history

Updated 4 times since Sep 2, 2026 · show changes
  1. v5

    Evidence sources 5 → 7

  2. v4

    Common questions revised

  3. v3

    Summary rewritten; Body revised

  4. v2

    Body revised

  5. v1

    Change tracking began

Related guides

  • CPAP as the weight comes off: managing sleep apnea on a GLP-1 · Tirzepatide (Zepbound) roughly halved sleep apnea severity in the SURMOUNT-OSA trials, and 42 to 50% of participants reached the trial's definition of resolution. That still left many with apnea, and the trials never tested stopping CPAP for good. This guide covers why you shouldn't retire your machine on your own, how pressure and mask fit change as weight comes off, when and how a repeat sleep test happens, and how an OSA diagnosis affects Zepbound coverage (as of September 2026).
  • How GLP-1 medications affect men vs. women: what the sex differences actually are · The same GLP-1 medication doesn't act quite the same in men and women. On average women lose more weight, report more side effects, and absorb more of the drug at the same body weight, differences driven partly by estrogen and testosterone. This guide covers what the research shows about sex differences in weight loss, tolerability, blood sugar and biology, and what it means for what you should expect.
  • Women's health on a GLP-1: birth control, pregnancy, PCOS, bone, and the things worth watching · For women, the biggest GLP-1 question is fertility. Tirzepatide can make the pill less reliable, weight loss can bring back ovulation you weren't expecting, and none of these drugs is safe in pregnancy, which is why "Ozempic babies" happen. This guide covers contraception and pregnancy planning, the PCOS trial evidence, protecting bone and muscle, the heart, and the menopause overlap.
  • Cortisol, stress, and weight on a GLP-1: what the connection really is · The "cortisol makes you fat" story is mostly overstated. Real cortisol excess, as in Cushing's syndrome, clearly drives central fat, but everyday stress does far less. On a GLP-1, cortisol matters more for muscle than for belly fat. This guide covers the evidence, how sleep affects cortisol, and why "cortisol-blocker" supplements don't hold up.
  • Sleep quality on a GLP-1: why it matters, what changes, and the sleep apnea connection · Sleep is the quiet variable in GLP-1 treatment. Short sleep can shift weight loss away from fat and toward muscle, GI side effects and hunger changes can disturb the night, and one GLP-1 medication is now FDA-approved to treat obstructive sleep apnea itself. This guide covers how sleep stages work, how treatment can affect them, and why protecting deep sleep helps protect your muscle.
  • Protecting your bones on a GLP-1: bone density, fracture risk, and what actually helps · Losing a lot of weight usually costs a small amount of bone, mostly at the hip, and GLP-1 weight loss is no exception. So far the fracture data are reassuring and the drug itself does not look like the main cause, but the long-term evidence is thin. Here's what the bone-density and fracture studies show, who should pay the most attention, and the levers that kept bone steady in trials: resistance and impact training, protein, calcium and vitamin D, and a well-timed bone scan.

Related terms

  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • LH and FSH · Luteinizing hormone and follicle-stimulating hormone: two pituitary hormones that signal the testes and ovaries to make sex hormones and sperm or eggs.
  • SHBG (sex hormone-binding globulin) · A protein that binds and transports sex hormones (including testosterone) in the blood. Obesity lowers SHBG, which reduces measured total testosterone and is a major reason obesity can look like low testosterone on a lab test.
  • Testosterone replacement therapy (TRT) · Replacing testosterone in men who have hypogonadism (clinically low testosterone plus symptoms), delivered as a gel, injection, patch, or pellet. It is for a specific diagnosis, not a default treatment for the reversible low testosterone that often accompanies obesity.
  • Hypogonadism · A condition of low sex-hormone production. In men it means low testosterone with symptoms; importantly, the low testosterone that often accompanies obesity is frequently a reversible state ('pseudo-hypogonadism') rather than true, pathologic hypogonadism.
  • Lean mass · Body weight from everything other than fat: mostly muscle, plus organs and water, and in the broad sense bone. On a DXA report, lean mass usually leaves bone out.
  • Resistance training (progressive overload) · Exercise that loads your muscles against resistance and is made gradually harder over time (progressive overload) to keep or build muscle and strength.
  • MACE (major adverse cardiovascular events) · A composite trial endpoint bundling cardiovascular death, non-fatal heart attack, and non-fatal stroke into a single outcome.

Was this helpful?

Improve this page